For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Whitehead Institute for Biomedical Research

USPTO Granted Patents = 317

% Expired Patents = 25.9

CIPO Patents = 3

EPO Patents = 43

Forward Citations = 6,349

Loading Chart...

Loading Chart...

439 inventors (with patents filed for the assignee):

Richard A Young (42 out of 49 patents)

Rudolf Jaenisch (32 out of 34 patents)

Susan Lindquist (29 out of 35 patents)

4. Harvey F Lodish (27 out of 34 patents)

5. David Sabatini (25 out of 25 patents)

6. Thomas Tuschl (24 out of 77 patents)

7. David P Bartel (18 out of 21 patents)

8. Hidde L Ploegh (17 out of 30 patents)

9. Robert Allan Weinberg (16 out of 24 patents)

10. Richard C Mulligan (15 out of 33 patents)

11. Sayda Mahgoub Elbashir (14 out of 57 patents)

12. Winfried Lendeckel (14 out of 28 patents)

13. Peter S Kim (14 out of 14 patents)

14. Eric Lander (12 out of 36 patents)

15. Konrad Hochedlinger (12 out of 12 patents)

Core Competencies:

Mammalian Genetics

Pluripotent Stem Cells

Protein Modification

Nanobody Imaging

Gene Expression

CRISPR-Cas Systems

Cell Reprogramming

Epigenetic Modifications

Cancer Stem Cells

RNA Interference

Bioactive Compounds

Transcription Regulation

317 patents: Sort by Forward Citations

1. 12644889 - VIRAL CONDENSATES AND METHODS OF USE THEREOF (2026-06-02),

2. 12577587 - COMPOSITIONS AND METHODS FOR MAMMALIAN GENETICS AND USES THEREOF (2026-03-17),

3. 12454576 - Nanobody based imaging and targeting of ECM in disease and development (2025-10-28),

4. 12419940 - Compositions and methods for modified dendrimer nanoparticle delivery (2025-09-23),

5. 12385055 - Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2 (2025-08-12),

6. 12371667 - Enhanced methods for inducing and maintaining naive human pluripotent stem cells (2025-07-29),

7. 12365884 - Compositions and methods for making epigenetic modifications (2025-07-22),

8. 12331311 - Protein modification of living cells using sortase (2025-06-17),

9. 12281314 - Methods and compositions for increasing protein expression and/or treating a haploinsufficiency disorder (2025-04-21),

10. 12252715 - Compositions and methods for making epigenetic modifications (2025-03-18),

11. 12241072 - Biosynthetic approach for heterologous production and diversification of bioactive lyciumin cyclic peptides (2025-03-04),

12. 12234453 - Regulation of transcription through CTCF loop anchors (2025-02-25),

13. 12146186 - HiC: method of identifying regulatory interactions between genomic loci (2024-11-19),

14. 12123019 - Uses of kinase inhibitors for inducing and maintaining pluripotency (2024-10-22),

15. 12068059 - Methods for building genomic networks and uses thereof (2024-08-20),

The Whitehead Institute for Biomedical Research is a non-profit research institute located in Cambridge, Massachusetts dedicated to improving human health through fundamental biological research. Established in 1982, the institute conducts pioneering research in the fields of genomics, cancer biology, developmental biology, stem cell biology, and infectious diseases. Whitehead Institute collaborates with leading academic, medical, and industry partners to translate discoveries into new treatments and therapies. Through its research programs, training initiatives, and public outreach, the institute aims to advance knowledge and create a better future for all.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Whitehead Institute for Biomedical Research

317 Patents

#11 in Cambridge, MA

#78 in Massachusetts

#1,387 in US

#2,826 in the World

Cambridge, MA, United States of America

Whitehead Institute for Biomedical Research

Forward Citations = 6,349

439 inventors:

Richard A Young (42 out of 49 patents)

Rudolf Jaenisch (32 out of 34 patents)

Susan Lindquist (29 out of 35 patents)

4. Harvey F Lodish (27 out of 34 patents)

5. David Sabatini (25 out of 25 patents)

Please report any incorrect information to [email protected]

Loading…